172 related articles for article (PubMed ID: 32392248)
1. PenDA, a rank-based method for personalized differential analysis: Application to lung cancer.
Richard M; Decamps C; Chuffart F; Brambilla E; Rousseaux S; Khochbin S; Jost D
PLoS Comput Biol; 2020 May; 16(5):e1007869. PubMed ID: 32392248
[TBL] [Abstract][Full Text] [Related]
2. lionessR: single sample network inference in R.
Kuijjer ML; Hsieh PH; Quackenbush J; Glass K
BMC Cancer; 2019 Oct; 19(1):1003. PubMed ID: 31653243
[TBL] [Abstract][Full Text] [Related]
3. A novel network control model for identifying personalized driver genes in cancer.
Guo WF; Zhang SW; Zeng T; Li Y; Gao J; Chen L
PLoS Comput Biol; 2019 Nov; 15(11):e1007520. PubMed ID: 31765387
[TBL] [Abstract][Full Text] [Related]
4. 'N-of-1-pathways' unveils personal deregulated mechanisms from a single pair of RNA-Seq samples: towards precision medicine.
Gardeux V; Achour I; Li J; Maienschein-Cline M; Li H; Pesce L; Parinandi G; Bahroos N; Winn R; Foster I; Garcia JG; Lussier YA
J Am Med Inform Assoc; 2014; 21(6):1015-25. PubMed ID: 25301808
[TBL] [Abstract][Full Text] [Related]
5. Disease characterization using a partial correlation-based sample-specific network.
Huang Y; Chang X; Zhang Y; Chen L; Liu X
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32422654
[TBL] [Abstract][Full Text] [Related]
6. [Precision medicine: A major step forward in specific situations, a myth in refractory cancers?].
Albin N; Mc Leer A; Sakhri L
Bull Cancer; 2018 Apr; 105(4):375-396. PubMed ID: 29501208
[TBL] [Abstract][Full Text] [Related]
7. LUADpp: an effective prediction model on prognosis of lung adenocarcinomas based on somatic mutational features.
Yu J; Hu Y; Xu Y; Wang J; Kuang J; Zhang W; Shao J; Guo D; Wang Y
BMC Cancer; 2019 Mar; 19(1):263. PubMed ID: 30902072
[TBL] [Abstract][Full Text] [Related]
8. Individual-level analysis of differential expression of genes and pathways for personalized medicine.
Wang H; Sun Q; Zhao W; Qi L; Gu Y; Li P; Zhang M; Li Y; Liu SL; Guo Z
Bioinformatics; 2015 Jan; 31(1):62-8. PubMed ID: 25165092
[TBL] [Abstract][Full Text] [Related]
9. Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DA.
Paul MR; Levitt NP; Moore DE; Watson PM; Wilson RC; Denlinger CE; Watson DK; Anderson PE
BMC Genomics; 2016 Mar; 17():263. PubMed ID: 27029813
[TBL] [Abstract][Full Text] [Related]
10. Big data and computational biology strategy for personalized prognosis.
Ow GS; Tang Z; Kuznetsov VA
Oncotarget; 2016 Jun; 7(26):40200-40220. PubMed ID: 27229533
[TBL] [Abstract][Full Text] [Related]
11. Pathway-based personalized analysis of cancer.
Drier Y; Sheffer M; Domany E
Proc Natl Acad Sci U S A; 2013 Apr; 110(16):6388-93. PubMed ID: 23547110
[TBL] [Abstract][Full Text] [Related]
12. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms.
Selvaraj G; Kaliamurthi S; Kaushik AC; Khan A; Wei YK; Cho WC; Gu K; Wei DQ
J Biomed Inform; 2018 Oct; 86():120-134. PubMed ID: 30195659
[TBL] [Abstract][Full Text] [Related]
13. Network controllability-based algorithm to target personalized driver genes for discovering combinatorial drugs of individual patients.
Guo WF; Zhang SW; Feng YH; Liang J; Zeng T; Chen L
Nucleic Acids Res; 2021 Apr; 49(7):e37. PubMed ID: 33434272
[TBL] [Abstract][Full Text] [Related]
14. Modeling gene-wise dependencies improves the identification of drug response biomarkers in cancer studies.
Nikolova O; Moser R; Kemp C; Gönen M; Margolin AA
Bioinformatics; 2017 May; 33(9):1362-1369. PubMed ID: 28082455
[TBL] [Abstract][Full Text] [Related]
15. MLW-gcForest: a multi-weighted gcForest model towards the staging of lung adenocarcinoma based on multi-modal genetic data.
Dong Y; Yang W; Wang J; Zhao J; Qiang Y; Zhao Z; Kazihise NGF; Cui Y; Yang X; Liu S
BMC Bioinformatics; 2019 Nov; 20(1):578. PubMed ID: 31726986
[TBL] [Abstract][Full Text] [Related]
16. Indel sensitive and comprehensive variant/mutation detection from RNA sequencing data for precision medicine.
Prodduturi N; Bhagwate A; Kocher JA; Sun Z
BMC Med Genomics; 2018 Sep; 11(Suppl 3):67. PubMed ID: 30255803
[TBL] [Abstract][Full Text] [Related]
17. Individualized identification of disease-associated pathways with disrupted coordination of gene expression.
Wang H; Cai H; Ao L; Yan H; Zhao W; Qi L; Gu Y; Guo Z
Brief Bioinform; 2016 Jan; 17(1):78-87. PubMed ID: 26023086
[TBL] [Abstract][Full Text] [Related]
18. Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis.
Huang S; Chong N; Lewis NE; Jia W; Xie G; Garmire LX
Genome Med; 2016 Mar; 8(1):34. PubMed ID: 27036109
[TBL] [Abstract][Full Text] [Related]
19. A Statistical Test for Differential Network Analysis Based on Inference of Gaussian Graphical Model.
He H; Cao S; Zhang JG; Shen H; Wang YP; Deng HW
Sci Rep; 2019 Jul; 9(1):10863. PubMed ID: 31350445
[TBL] [Abstract][Full Text] [Related]
20. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
